As a simple and rapid method for small-molecule analysis, matrix-assisted laser desorption ionization coupled with linear ion-trap tandem mass spectrometry (MALDI-LTQ-MS/MS) was used to differentially quantify 2-and 4-methoxyestrogens in spiked serum samples. Both 2-and 4-methoxyestrogens were consistently identified using distinct analyte-matrix adduct [M+H+CHCA] + precursor ions when a mixture of 10 mg mL -1 α-cyano-4-hydroxycinnamic acid (CHCA) in 0.2% trifluoroacetic acid/70% acetonitrile was used as the MALDI matrix. Especially, unusual isomeric product ions from each precursor ion were characterized during MALDI-MS/MS analysis, which permitted differential estimations of isomeric 2-and 4-methoxylated estrone and 17β-estradiol. The calibration linearity was higher than 0.99 in the dynamic range, while the inter-day precision and accuracy ranged from 6.8 to 30.6%, and from 91.4 to 108.5%, respectively. The present technique could be used as a screening assay for 2-and 4-methoxyestrogens without the need for prior chromatographic separation, opening up possible applications in large-scale pharmacokinetic studies.
Introduction
Methoxyestrogens are endogenous estrogen metabolites produced from estrone and 17β-estradiol by sequential hydroxylation and O-methylation at the 2-and 4-positions via cytochrome P450 (CYP) enzymes (CYP1A1, CYP1B1) and catechol-O-methyltransferase (COMT). 1 Although methoxyestrogens have poor affinity for the estrogen receptor, the effects of 2-methoxyestradiol, a major methoxyestrogen metabolite, have been reported to inhibit the proliferative activity of various tumor cells and vascular smooth muscle cells, and to protect against atherosclerosis and vascular injury in preclinical models. [2] [3] [4] Conventional methods for quantifying endogenous methoxyestrogens rely on radioimmunoassays as well as gas or liquid chromatography in conjunction with mass spectrometry (GC-MS or LC-MS). [5] [6] [7] [8] The applicability of immunochemical methods is limited due to cross-reactions with similar estrogenic species, resulting in an overestimation of the analyte concentration; 9 in contrast, chromatography-mass spectrometry-based methods have displayed superior quantitative determination with good sensitivity and reproducibility despite drawbacks, such as time-consuming chemical derivatization required for GC-MS analysis, as well as long separation times and poor ionization from ion suppression in LC-MS analysis. 7, 8 Recently, matrix-assisted laser desorption ionization coupled to MS (MALDI-MS) has shown promise as an emerging high-throughput screening tool for the analysis of lipid molecules below 500 Da. [10] [11] [12] [13] [14] Quantitative analysis using MALDI techniques is still problematic because of interference peaks in the low-m/z region derived from matrices, such as α-cyano-4-hydroxycinnamic acid (CHCA) and 2,5-dihydroxybenzoic acid (DHB), as well as unreliable discrimination between isomeric analytes. [10] [11] [12] Our preliminary results include the successful quantitative analysis of adrenal steroids from underivatized samples with good reproducibility using MALDI-linear ion-trap-tandem MS (LTQ-MS/MS) and internal standards, indicating that MALDI-MS/MS could be applied to the analysis of clinical samples. 13 To resolve the problem of separating isomeric compounds, several methods have been employed by using off-or on-line coupling of MALDI with column separation (LC), planar separation (e.g., thin-layer chromatography or gels), and solidphase extraction (SPE). 10 To date, isomeric small molecules have not been differentiated in MALDI-MS without prior chromatographic separation.
Here, we describe the differential quantification of isomeric 2-and 4-methoxyestrogens in serum by MALDI-LTQ-MS/MS using the conventional CHCA matrix. Four methoxyestrogens, 2-and 4-methoxyestrone and 2-and 4-methoxyestradiol, were consistently identified through distinct precursor ions derived from the formation of analyte-matrix adducts under optimized matrix and instrumental conditions. Moreover, unusual isomeric fragment ions from each precursor ion were characterized during MALDI-MS/MS analysis, which enabled differentiation between isomeric 2-and 4-methoxylated estrogens in spiked serum samples.
Experimental

Reagents and chemicals
The four methoxylated estrogens (2-methoxyestrone (2-MeO-E1), 2-methoxy-17β-estradiol (2-MeO-E2), 4-methoxyestrone (4-MeO-E1), and 4-methoxy-17β-estradiol (4-MeO-E2)), examined in this study were obtained from Steraloids (Newport, RI). The deuterium-labeled internal standard (IS), 2,4,16,16-d4-17β-estradiol (d4-E2, isotopic purity ≥ 98%) was purchased from C/D/N isotopes (Pointe-Claire, Quebec, Canada). Stock solutions of reference standards were prepared at a concentration of 1 mg mL -1 in methanol. Working solutions were diluted with methanol to various concentrations ranging from 0.1 to 10 μg mL -1 . All standard solutions were stored at -20 C prior to use.
CHCA was purchased from Sigma (St. Louis, MO). For SPE, Oasis HLB (3 cc, 60 mg; Waters, Milford, MA) preconditioned with 2 mL of methanol, followed by 2 mL of deionized water, was used. Sodium phosphate monobasic (reagent grade), sodium phosphate dibasic (reagent grade), sodium acetate (reagent grade, anhydrous), acetic acid (glacial, 99.99+%), and trifluoroacetic acid (TFA) were acquired from Sigma. All analytical or HPLC-grade organic solvents were purchased from Burdick & Jackson (Muskegon, MI). Deionized water was prepared using a Milli-Q purification system (Millipore, Billerica, MA).
Sample preparation
Quantitative estrogen profiling was performed based on a previous report. 15 Briefly, a serum sample (0.4 mL) was diluted with 2.6 mL of acetate buffer (0.2 M, pH 5.2), and 20 μL of d4-E2 (1 μg mL -1 ) IS was added. The samples were extracted with Oasis HLB TM SPE cartridges placed in a device fitted with a small peristaltic pump, and operated at a low flow rate (<1 mL min -1 ). After loading a sample on a cartridge, it was washed with 2 mL of water, and eluted twice with 2 mL of methanol. The combined eluate was evaporated under a nitrogen stream, and then dissolved in 1 mL of 0.2 M phosphate buffer (pH 7.2). This solution was extracted twice with 2.5 mL of ethyl acetate/n-hexane (2:3, v/v). The organic solvent was evaporated in on N2 evaporator at 40 C, and further dried in a vacuum desiccator over P2O5-KOH for at least 30 min.
Finally, the dried residue was combined with 20 μL of matrix (10 mg mL -1 CHCA in 0.2% TFA/70% acetonitrile), and was then vortexed for 10 s; 1 μL of the mixture was spotted onto a 384-well stainless-steel MALDI plate and analyzed using MALDI-MS in a selected reaction-monitoring (SRM) mode.
MALDI-linear ion trap mass spectrometry
A Finnigan LTQ linear ion trap coupled to a Finnigan MALDI (Thermo Finnigan, San Jose, CA) ion source was used for MALDI-MS/MS analysis. The data were acquired using Xcalibur 2.0.7 software in the data-dependent mode. Pulsed nitrogen was emitted at 337 nm through a fiber-optic cable; the extraction voltage was 20 kV. Helium was used as the collision gas during collision induced dissociation (CID). The laser position was controlled using a spiral outward, using the positive-ion mode, an optimal laser energy of 8 μJ, and an isolation width of m/z 0.5. A survey mass scan was followed by MS/MS scans on the most abundant ions to identify the SRM transitions, which are listed in Table 1 . The analysis of each sample spot was repeated three times.
Differential quantification and validation
For calibration and quality-control (QC) purposes, commercially available steroid-free serum (Scipac; Sittingbourne, UK) was used. Four samples with different concentrations of methoxylated estrogens in serum, as a biological matrix, were analyzed to confirm the accuracy of the calibration. A calibration curve was constructed by measuring the concentration of seven calibrators (0, 20, 50, 100, 200, 375, and 500 ng mL -1 ) in triplicate. Least-squares regression analysis was performed using the intensity ratio of the analyte to the IS against increasing amounts to obtain calibration linearity. The limit of detection (LOD) and quantification (LOQ) of each analyte were estimated based on the lowest concentration that yielded a peak in the MALDI mass spectrum that exceeded the threshold established as the mean average of 10 blank samples + n × standard deviation (where n = 3.3 for the LOD and 10 for the LOQ). 13 The precision, expressed as the coefficient of variation (% CV), and the accuracy, expressed as the percentage relative error (% bias) of the method, were determined from the analysis of QC samples in triplicate at three different concentrations (low, medium, and high, at 50, 200, and 375 ng mL -1 , respectively) based on the calibration range of each analyte. The within-day repeatability was determined from three replicates, whereas the reproducibility was assessed from results obtained over 5 different days.
Results and Discussion
Optimization of MALDI matrix and instrumental conditions
CHCA is commonly used as a MALDI matrix; it has also been employed in binary matrices with DHB and 9-aminoacridine for the quantitative analysis of serum adrenal steroids. 13 In this study, CHCA formed small round crystals that were quite homogenously distributed throughout the sample spot on the MALDI plate, promoting better reproducibility of the signal intensity. Four matrix solvents were tested, including acetonitrile (ACN), isopropanol (IPA):ACN (6:4, v/v), methanol, and acetone, at a ratio of 70:30 solvent/deionized water with 0.2% TFA and 10 mg mL -1 CHCA (Fig. 1) . The choice of the matrix composition greatly impacted the performance and the interpretation of the MALDI-MS analysis of 2-and 4-methoxylated estrogens in serum samples. Next, motion patterns for the laser position on the MALDI sample plate (spiral inward, spiral outward, zigzag, and a crystal positioning system) were tested, and a preprogrammed spiral search pattern was selected. The laser power, isolation width, and collision energy were also optimized to obtain product ion mass spectra with high intensity and signal-to-noise ratios (S/N) of the fragment peaks. Because the laser energy determined the number of ions entering the ion trap, the laser energy was tested from 4 to 10 μJ, with 8.0 μJ selected as being the optimal value. The optimal isolation width (m/z) was 0.5 for all compounds, and the collision energy was set to 60% for d4-E2 IS and 40% for the four methoxyestrogens. No significant difference was found in the signal intensity of the target compounds when the sample spot volume was varied from 0.5 to 1.5 μL, so the middle of the range (1.0 μL spot size) was chosen. On average, the total analysis time was 1 min, including the acquisition time for averaging 75 scans and a delay for adjusting the laser intensity and repositioning the sample plate.
Identification of methoxylated estrogens by MALDI-MS
Representative positive-ionization MALDI-LTQ-MS spectra of 2-and 4-methoxylated estrogens are shown in Fig. 2 16 Peak identification was achieved by comparisons with the CHCA matrix peak so as to avoid any overlap with the analyte signals. Interestingly, both 2-and 4-methoxyestrogens in full-scan MS spectra produced the analyte-matrix adduct [M+H+CHCA] + , as opposed to adrenal steroids which predominantly produce the protonated molecule [M+H] + under the same matrix conditions. 13 2-and 4-MeO-E1 and 2-and 4-MeO-E2 were detected at m/z 490 and m/z 492, respectively, as a [M+H+CHCA] + peak, which was selected as the precursor ion for MS/MS analysis (Fig. 2) .
Recently, several phenomena related to adduct formation in MALDI-MS small-molecule analysis have been reported. 17, 18 Analyte-matrix adducts were observed in MALDI-TOF-MS analyses of aliphatic primary and secondary amines using 2-[(2E)-3-(4-tert-butylphenyl)-2-methylprop-2-enylidene] malononitrile (DCTB) as a matrix, thought to be caused by nucleophilic reactions between DCTB molecules/radical cations and analyte amino groups. 17 Also reported was the detection of biomolecules, including amino acids, peptides, and fatty acids as matrix-analyte adducts that appeared in the higher mass region, using metal-phthalocyanines (MPcs) as matrices; the possible mechanisms proposed for analyte-matrix adduct formation included π-π or electrostatic interactions between the analyte and MPc. 18 In this study, analyte-CHCA adduct formation was observed only for estrogens, and not for other steroid molecules analyzed by MALDI-MS. No difference in the intensity of the target ion was observed when the mixing time of methoxyestrogens with the CHCA matrix was varied between 10 and 30 s, suggesting that methoxylated estrogens easily form adducts with the CHCA matrix. Based on the chemical structures of CHCA and the methoxylated estrogens, adducts could form through π-π interactions between the aromatic ring of the estrogens and the phenyl group of CHCA, cation-π interactions between the aromatic ring of the estrogens and the cyano group of CHCA, or through general hydrogen bonding between the two compounds. 19 Although interactions between the analyte and CHCA are not very strong, the ions [M+H+CHCA] + were selected as precursor ions to produce specific fragments of isomeric 2-and 4-methoxylated estrogens. The devised method is the first report, demonstrating that methoxyestrogens can be detected by MALDI-MS as analyte-matrix adducts using CHCA as the matrix, which resulted in good selectivity through the movement of small molecules.
Separation of isomeric methoxylated estrogens by MALDI-MS/MS
To determine the feasibility of methoxyestrogen quantification using MALDI, tandem MS was performed using the analyte-matrix adducts at m/z 490 for 2-and 4-MeO-E1 and m/z 492 for 2-and 4-MeO-E2 as precursor ions (Fig. 3) . The However, a distinct difference in the fragmentation patterns for the isomeric compounds 2-and 4-MeO-E1 was observed; an elimination of 89 Da from the precursor [M+H+CHCA] + producing an additional dominant peak at m/z 401 was observed only in the 4-MeO-E1 spectrum. This specific product ion was discriminated from interfering compounds, such as the CHCA matrix and the matrix in human serum. Likewise, the isomeric compounds 2-and 4-MeO-E2 produced two common, predominant product ions at m/z 303 ( . 20 In addition to the observed [M+H+CHCA-89] + peak in the spectra of only the 4-methoxyestrogens, we also observed a higher intensity of the [M+H+CHCA-H2O] + peak for these analytes, as compared to the 2-methoxyestrogens in MALDI-MS/MS spectra (Fig. 3) . These phenomena suggest an easier elimination of the 89 Da or H2O groups at C-4 than at the C-2 position of methoxyestrogens, presenting the possibility that the 4-methoxy substituent is more active, or less sterically hindered, than the 2-methoxy substituent, although the fragmentation pathways are not yet well understood.
Compared to the GC-or LC-MS techniques, the separation of isomeric and isomeric compounds has proven to be difficult in the application of MALDI-MS to small molecules. In preliminary tests, chemical derivatization of methoxyestrogens using dansyl chloride, a reagent that reacts with aromatic groups to produce stable sulfonamide adducts, 8 was performed to assess whether the derivatives yielded specific product ions useful for discrimination between isomeric methoxyestrogens. However, the distinct product ions that differentiated the 2-and 4-methoxyestrogens were no longer detected after dansylation, and similar fragmentation patterns for 2-and 4-MeO-E1 and 2-and 4-MeO-E2 were observed in the MALDI-MS/MS spectra (data not shown). It is apparent that MALDI-MS/MS without chemical derivatization was the most effective, and simplest, for distinguishing isomeric methoxyestrogens.
Quantification of methoxylated estrogens by MALDI-MS/MS
All quantitative results obtained using MS/MS analysis were calculated using the characteristic peaks as the quantitative ion, including m/z 283, 301, and 401 for 2-and 4-methoxyestrone and m/z 285, 303, and 403 for 2-and 4-methoxyestradiol. It was determined whether the product ion at m/z 401 or 403 enabled differentiation between 2-and 4-methoxylated estrogens (Fig. 4) . To overcome the poor point-to-point repeatability and sample-to-sample reproducibility of quantification using MALDI-MS/MS, a deuterium-labeled d4-E2 was used as an IS, which was chemically similar to the analyte, and stable during the analysis. Averaging values over three replicate measurements was implemented in order to minimize the deviations of the analyte-to-IS signal ratio, and to improve the experimental reproducibility. This approach produced excellent linearity of detection (correlation coefficient, r 2 > 0.99) in the concentration range from 20 to 500 ng mL -1 for the four methoxyestrogens. Moreover, the linearity of the calibration curve at m/z 401 and 403 was acceptable only in 4-methoxyestrogens with r 2 > 0.99 (not 2-methoxyestrogens), thus ensuring proper identification and quantification between the isomeric methoxylated estrogens in spiked serum samples.
Based on the specific product ions for the quantification of methoxyestrogens in MALDI-MS/MS, the LOQs were determined to be 21.7 -39.3 ng mL -1 in the calibration ranges used ( Table 2 ). The intra-day (n = 3) precision (expressed as % CV) ranged from 4.5 to 29.5%, whereas the accuracy (expressed as % bias) ranged from 90.1 to 116.8%; inter-day (n = 5) precision (% CV), and the accuracy (% bias) ranged from 6.8 to 30.6% and from 91.4 to 108.5%, respectively (Table 2 ). In particular, the CV values as a measure of reproducibility were less than 30%, which is very good compared with other MALDI studies, where CV values of greater than 50% and up to 200% have frequently been reported. 21 
Conclusions
A novel strategy to detect and quantify isomeric methoxyestrogens in spiked serum samples as a biological matrix, using the conventional CHCA matrix by MALDI-MS/ MS, was successfully achieved. Both 2-and 4-methoxyestrogens were evaluated through distinct precursor peaks as analytematrix adducts, and specific product ions from each precursor ion were used to achieve the differential quantification of isomeric 2-and 4-methoxylated estrogens. Improved precision and accuracy over previous MALDI-MS analyses of small molecules suggests that this approach could be used as a simple, rapid, and reproducible screening technique for 2-and 4-methoxyestrogens without the need for prior chromatographic separation. The low intensive precursor ion, [M+H+CHCA] + , is one of the reasons for poor sensitivity, but the devised technique may be applicable to large-scale pharmacokinetic and pharmacodynamic studies from in vitro or in vivo models. a. The limit of detection (LOD) was estimated based on the lowest concentration given by blank matrix standard deviation over the slope of calibration. b. The limit of quantification (LOQ) was calculated based on 3.3 times the LOD calculated concentration. c. Precision and accuracy are expressed as the mean values of data obtained from three QC samples through intra-and inter-day assays.
